Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind double-dummy placebo- and active-controlled multicenter trial of Sanhua Qingjie Granules for acute upper respiratory tract infection (wind-heat syndrome)
CTR20264094Phase 2Active
- Sponsor
- Guangdong Fangsheng Rongke Pharmaceutical
- Start
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Sanhua Qingjie Granules in upper respiratory infection (URI), sponsored by Guangdong Fangsheng Rongke Pharmaceutical. Started Oct 2026; status: active.
02
Drugs
Sanhua Qingjie Granules
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20264094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20264094.